BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 37321467)

  • 21. Junctional adhesion molecule-like protein promotes tumor progression via the Wnt/β-catenin signaling pathway in lung adenocarcinoma.
    Wu Q; Li R; Wang QX; Zhang MY; Liu TT; Qu YQ
    J Transl Med; 2022 Jun; 20(1):260. PubMed ID: 35672776
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-15b enhances the proliferation and migration of lung adenocarcinoma by targeting BCL2.
    Wang J; Yao S; Diao Y; Geng Y; Bi Y; Liu G
    Thorac Cancer; 2020 Jun; 11(6):1396-1405. PubMed ID: 32220063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plakophilin-2 accelerates cell proliferation and migration through activating EGFR signaling in lung adenocarcinoma.
    Hao XL; Tian Z; Han F; Chen JP; Gao LY; Liu JY
    Pathol Res Pract; 2019 Jul; 215(7):152438. PubMed ID: 31126818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Actin-like protein 8 promotes cell proliferation, colony-formation, proangiogenesis, migration and invasion in lung adenocarcinoma cells.
    Ma S; Wang X; Zhang Z; Liu D
    Thorac Cancer; 2020 Mar; 11(3):526-536. PubMed ID: 31962007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discoidin domain receptor 1 promotes lung adenocarcinoma migration via the AKT/snail signaling axis.
    Zhu J; Cheng H; Wang L; Xu W; Wang J; Han Q; Lee JH; Du L; Lyu J
    Mol Biol Rep; 2022 Aug; 49(8):7275-7286. PubMed ID: 35562515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGF2BP3 aggravates lung adenocarcinoma progression by modulation of PI3K/AKT signaling pathway.
    Chen X; Zhu X; Shen X; Liu Y; Fu W; Wang B
    Immunopharmacol Immunotoxicol; 2023 Jun; 45(3):370-377. PubMed ID: 36972188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA cMras inhibits lung adenocarcinoma progression via modulating miR-567/PTPRG regulatory pathway.
    Yu C; Tian F; Liu J; Su M; Wu M; Zhu X; Qian W
    Cell Prolif; 2019 May; 52(3):e12610. PubMed ID: 31012177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The lncRNA ALMS1-IT1 may promote malignant progression of lung adenocarcinoma via AVL9-mediated activation of the cyclin-dependent kinase pathway.
    Luan T; Zhang TY; Lv ZH; Guan BX; Xu JY; Li J; Li MX; Hu SL
    FEBS Open Bio; 2021 May; 11(5):1504-1515. PubMed ID: 33683834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PPP1R14D promotes the proliferation, migration and invasion of lung adenocarcinoma via the PKCα/BRAF/MEK/ERK signaling pathway.
    Cao H; Wang Z; Wang Y; Ye L; Li R; Xue Y; Li K; Di T; Li T; Fan Z; Liu Y; Guo J; Yao H; Ge C
    Int J Oncol; 2022 Dec; 61(6):. PubMed ID: 36263632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53-inducible gene 3 promotes cell migration and invasion by activating the FAK/Src pathway in lung adenocarcinoma.
    Gu MM; Gao D; Yao PA; Yu L; Yang XD; Xing CG; Zhou J; Shang ZF; Li M
    Cancer Sci; 2018 Dec; 109(12):3783-3793. PubMed ID: 30281878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of eIF6 as a prognostic factor that drives tumor progression and predicts arsenic trioxide efficacy in lung adenocarcinoma.
    Shen Y; Zhang R; Li X
    Mol Biol Rep; 2023 Feb; 50(2):1167-1180. PubMed ID: 36435920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overexpression of BCCIP predicts an unfavorable prognosis and promotes the proliferation and migration of lung adenocarcinoma.
    Shi J; Lv X; Li W; Ming Z; Zeng L; Yuan J; Chen Y; Liu B; Yang S
    Thorac Cancer; 2021 Sep; 12(17):2324-2338. PubMed ID: 34297484
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PAR2 Promoter Hypomethylation Regulates PAR2 Gene Expression and Promotes Lung Adenocarcinoma Cell Progression.
    Wu K; Xu L; Cheng L
    Comput Math Methods Med; 2021; 2021():5542485. PubMed ID: 33968158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Agmatinase promotes the lung adenocarcinoma tumorigenesis by activating the NO-MAPKs-PI3K/Akt pathway.
    Zhu HE; Yin JY; Chen DX; He S; Chen H
    Cell Death Dis; 2019 Nov; 10(11):854. PubMed ID: 31699997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LDH-A promotes malignant behavior via activation of epithelial-to-mesenchymal transition in lung adenocarcinoma.
    Hou XM; Yuan SQ; Zhao D; Liu XJ; Wu XA
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30509961
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PSMA5 contributes to progression of lung adenocarcinoma in association with the JAK/STAT pathway.
    Lu F; Zhou J; Chen Q; Zhu J; Zheng X; Fang N; Qiao L
    Carcinogenesis; 2022 Aug; 43(7):624-634. PubMed ID: 35605971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RHOV promotes lung adenocarcinoma cell growth and metastasis through JNK/c-Jun pathway.
    Zhang D; Jiang Q; Ge X; Shi Y; Ye T; Mi Y; Xie T; Li Q; Ye Q
    Int J Biol Sci; 2021; 17(10):2622-2632. PubMed ID: 34326698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA MAFG-AS1 Promotes Lung Adenocarcinoma Cell Migration and Invasion by Targeting miR-3196 and Regulating SOX12 Expression.
    Wu Q; Jiang J
    Mol Biotechnol; 2022 Sep; 64(9):970-983. PubMed ID: 35275356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.
    Feng H; Zhang Z; Qing X; French SW; Liu D
    Exp Mol Pathol; 2019 Jun; 108():105-113. PubMed ID: 30981721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long noncoding RNA LINC00483 promotes lung adenocarcinoma progression by sponging miR-204-3p.
    Yang S; Liu T; Sun Y; Liang X
    Cell Mol Biol Lett; 2019; 24():70. PubMed ID: 31889958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.